Technical Analysis for OPTN - OptiNose, Inc.

Grade Last Price % Change Price Change
F 3.7 3.35% 0.12
OPTN closed up 3.35 percent on Thursday, April 22, 2021, on 41 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical OPTN trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Above Upper BB Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Crossed Above 20 DMA Bullish 3.35%
Bollinger Band Squeeze Range Contraction 3.35%
Bollinger Band Squeeze Range Contraction 5.71%
BB Squeeze + Lower Band Touch Range Contraction 5.71%
Older End-of-Day Signals for OPTN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Upper Bollinger Band Resistance about 15 hours ago
Rose Above Previous Day's High about 16 hours ago
Rose Above Upper Bollinger Band about 16 hours ago
Up 3% about 16 hours ago
Up 2% about 16 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

OptiNose, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The Company’s lead product, XHANCE (fluticasone propionate) nasal spray, utilizes breath powered exhalation delivery system (EDS), to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. XHANCE has a differentiated clinical profile with the potential to become part of the standard of care for this disease because it is able to deliver medication to the primary site of inflammation
Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Clinical Medicine Pharmaceutical Organ Systems Disease Inflammation Respiratory Therapy Polyp Allergy Icos Sinus Glucocorticoids Nasal Spray Corticosteroid Sinusitis Chronic Rhinosinusitis Fluticasone Nasal Polyps

Is OPTN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.0
52 Week Low 3.14
Average Volume 431,519
200-Day Moving Average 4.27
50-Day Moving Average 3.79
20-Day Moving Average 3.55
10-Day Moving Average 3.55
Average True Range 0.16
ADX 18.76
+DI 22.36
-DI 19.83
Chandelier Exit (Long, 3 ATRs ) 3.26
Chandelier Exit (Short, 3 ATRs ) 3.81
Upper Bollinger Band 3.69
Lower Bollinger Band 3.41
Percent B (%b) 1.05
BandWidth 7.68
MACD Line -0.05
MACD Signal Line -0.08
MACD Histogram 0.0291
Fundamentals Value
Market Cap 192.7 Million
Num Shares 52.1 Million
EPS -2.61
Price-to-Earnings (P/E) Ratio -1.42
Price-to-Sales 4.25
Price-to-Book 7.62
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.96
Resistance 3 (R3) 3.95 3.85 3.92
Resistance 2 (R2) 3.85 3.78 3.85 3.90
Resistance 1 (R1) 3.77 3.74 3.81 3.79 3.89
Pivot Point 3.67 3.67 3.69 3.68 3.67
Support 1 (S1) 3.60 3.61 3.64 3.61 3.51
Support 2 (S2) 3.50 3.57 3.51 3.50
Support 3 (S3) 3.43 3.50 3.48
Support 4 (S4) 3.44